In TME, TAMs facilitate the immune shift of the tumor cells by releasing anti-inflammatory cytokines such as TGF-β and IL-10, which subscribe to the suppression of effector T cell and natural killer (NK) cell cytotoxicity [47]. This evidence concerns the gene IL10 and neoplasm.